Personalized medicine in rheumatology

about

Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice.

P2860

Q55044448-0935AEC3-CF9A-4572-A0E4-A7DDC4311499

P2860

Personalized medicine in rheumatology

Item

http://www.wikidata.org/entity/Q28077413

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Personalized medicine in rheumatology

@ast

Personalized medicine in rheumatology

@en

Personalized medicine in rheumatology

@nl

type

Item

label

Personalized medicine in rheumatology

@ast

Personalized medicine in rheumatology

@en

Personalized medicine in rheumatology

@nl

prefLabel

Personalized medicine in rheumatology

@ast

Personalized medicine in rheumatology

@en

Personalized medicine in rheumatology

@nl

P1476

Personalized medicine in rheumatology

@en

P2093

Brygida Kwiatkowska

http://www.w3.org/2001/XMLSchema#string

Filip Raciborski

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

Knowledge-based analysis of genetic associations of rheumatoid arthritis to inform studies searching for pleiotropic genes: a literature review and network analysis

Gene expression analysis in RA: towards personalized medicine

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Use of RNA sequencing to evaluate rheumatic disease patients

Genetic data: The new challenge of personalized medicine, insights for rheumatoid arthritis patients.

Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets.

Pharmacogenetics and pharmacogenomics in rheumatology.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα

P304

177-186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3123741

http://www.w3.org/2001/XMLSchema#string

P356

10.5114/REUM.2016.62472

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Agnieszka Paradowska-Gorycka

Anna Kłak

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27826172

http://www.w3.org/2001/XMLSchema#string

P932

5090026

http://www.w3.org/2001/XMLSchema#string

Personalized medicine in rheumatology

about

P2860

P2860

Personalized medicine in rheumatology

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P698

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P698

P932